Please write a SOAP note for a patient presenting with tongue swelling (angioedema) who is not taking an ACE inhibitor.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

SOAP Note: Swollen Tongue (Non-ACE Inhibitor Related)

Subjective

Chief Complaint: Tongue swelling

History of Present Illness:

  • Onset: Acute vs. recurrent episodes (timing, duration, frequency)
  • Duration of current episode and pattern of progression (typically worsens over 24 hours, peaks, then resolves over 48 hours in bradykinin-mediated angioedema) 1
  • Associated symptoms:
    • Absence of urticaria or pruritus (suggests non-histaminergic/bradykinin-mediated angioedema rather than allergic) 1
    • Difficulty breathing, dysphagia, voice changes, stridor (airway compromise indicators)
    • Abdominal pain, extremity swelling, facial swelling
    • Prodromal symptoms (tingling, erythema marginatum-like rash)
  • Triggers: Trauma, stress, dental procedures, infections, menstruation
  • Previous episodes and their management

Medication History:

  • Confirm NO ACE inhibitor use (lisinopril, enalapril, perindopril, etc.)
  • Screen for ARBs (losartan, valsartan) - can also rarely cause angioedema 1
  • DPP-4 inhibitors (sitagliptin, saxagliptin) - increase angioedema risk, especially with concurrent ACE-I 1
  • NSAIDs, estrogens, other antihypertensives
  • Recent medication changes

Family History:

  • Critical: Family history of angioedema or unexplained deaths (suggests hereditary angioedema) 1
  • Age of onset in family members (typically childhood/puberty for HAE) 1

Allergies:

  • Recent food exposures (eggs, shellfish, nuts)
  • Insect stings (bee, wasp)
  • Drug reactions 2

Objective

Vital Signs:

  • Respiratory rate, oxygen saturation, blood pressure, heart rate
  • Signs of airway compromise are life-threatening priority

Physical Examination:

  • Airway assessment:

    • Tongue size and position (protrusion beyond teeth, floor of mouth involvement)
    • Oropharyngeal edema, uvular swelling
    • Voice quality (muffled voice, hot potato voice)
    • Stridor, drooling, inability to handle secretions
    • Unilateral vs. bilateral involvement (unilateral is rare but reported) 3
  • Skin examination:

    • Presence or absence of urticaria (urticaria suggests mast cell-mediated/allergic; absence suggests bradykinin-mediated) 1
    • Non-pitting, non-erythematous swelling characteristic of angioedema
    • Distribution: face, lips, extremities, genitourinary area
  • Abdominal examination: Tenderness (bowel wall edema in HAE)

Assessment

Differential Diagnosis (Non-ACE Inhibitor Angioedema):

  1. Hereditary Angioedema (HAE) - Most critical to identify 4, 1

    • Type I: Low C1-INH antigenic and functional levels (most common)
    • Type II: Normal C1-INH antigenic, low functional levels
    • Type III: Normal C1-INH (diagnosis by exclusion)
  2. Acquired C1 Inhibitor Deficiency 1

    • Associated with lymphoproliferative disorders, autoantibodies
    • Typically later onset (>40 years)
  3. Allergic/Mast Cell-Mediated Angioedema 2

    • IgE-mediated (food, drugs, insect stings)
    • Usually accompanied by urticaria, pruritus
    • Responds to antihistamines/epinephrine
  4. Idiopathic Angioedema

    • Diagnosis of exclusion

Diagnostic Workup:

Immediate (if not already done):

  • C4 level - screening test (low in HAE and acquired C1-INH deficiency) 1
  • C1 inhibitor antigenic level
  • C1 inhibitor functional level 1
  • C1q level - normal in HAE, low in acquired C1-INH deficiency 1

If C1-INH deficiency confirmed:

  • Genetic testing for HAE mutations
  • Workup for underlying lymphoproliferative disorder if acquired type suspected 1

If normal complement studies:

  • Tryptase level (if suspecting mast cell-mediated)
  • Specific IgE testing for suspected allergens
  • Consider idiopathic angioedema

Plan

Acute Management

Airway is Priority:

  • Continuous monitoring in controlled environment for potential intubation 1
  • Low threshold for early intubation or cricothyroidotomy if airway compromise 2, 5

Pharmacologic Management:

If Histamine-Mediated (with urticaria/pruritus):

  • Epinephrine 0.3-0.5 mg IM
  • H1 antihistamines (diphenhydramine 50 mg IV/IM)
  • H2 antihistamines (ranitidine or famotidine)
  • Corticosteroids (methylprednisolone 125 mg IV)

If Bradykinin-Mediated (HAE or acquired C1-INH deficiency - no urticaria):

  • Antihistamines, corticosteroids, and epinephrine are NOT efficacious 1
  • C1-INH replacement therapy (if available and confirmed diagnosis)
  • Icatibant (bradykinin B2 receptor antagonist) - reported efficacy 1
  • Ecallantide (kallikrein inhibitor) - reported efficacy 1
  • Fresh frozen plasma - often effective but may acutely exacerbate some attacks; use with caution 1

Long-Term Management

If HAE Confirmed:

  • Referral to immunology/allergy specialist
  • Long-term prophylaxis options:
    • Androgens (danazol, stanozolol)
    • Antifibrinolytic agents (tranexamic acid)
    • C1-INH replacement therapy
  • Avoid triggers (trauma, estrogens, ACE inhibitors) 1
  • Patient education on attack recognition and emergency management
  • Prescription for on-demand therapy

If Acquired C1-INH Deficiency:

  • Treatment of underlying condition (lymphoma, autoimmune disease) 1
  • Antifibrinolytic drugs often more effective than androgens (unlike HAE) 1
  • Consider rituximab for autoantibody-positive cases 1

If Allergic Angioedema:

  • Allergen avoidance
  • Epinephrine auto-injector prescription
  • Antihistamine prophylaxis if recurrent

If Idiopathic:

  • Trial of antihistamines
  • Consider omalizumab if refractory

Medication Adjustments

  • Permanently avoid ACE inhibitors (even if not current cause, contraindicated in C1-INH deficiency) 1
  • Caution with ARBs - modest cross-reactivity risk 1
  • Avoid estrogens in C1-INH deficiency 5

Follow-Up

  • Allergy/Immunology referral for confirmed or suspected HAE/acquired C1-INH deficiency
  • Repeat complement studies if initial results pending
  • Document episode characteristics for pattern recognition
  • Emergency action plan and medical alert identification

Critical Pitfall: Do not assume angioedema without urticaria will respond to standard allergic treatment (antihistamines/steroids/epinephrine). Bradykinin-mediated angioedema requires specific targeted therapy 1.

Related Questions

Can you provide a SOAP note for a patient presenting with acute swelling of the anterior two‑thirds of the tongue (angioedema), with sudden onset, mild dysphonia and throat tightness, no drooling, vomiting, or urticaria, recent initiation of an ACE inhibitor, no prior episodes of angioedema, no asthma or atopic disease, vital signs showing normotension, mild tachycardia, normal respiratory rate, normal oxygen saturation, and afebrile?
How long does angioedema caused by an angiotensin‑receptor blocker typically last, and how long does tongue swelling take to resolve?
I developed facial swelling a few hours after my first dose of lisinopril (ACE inhibitor) without tongue swelling—should I stop the medication and seek emergency care?
How should ACE inhibitor–induced angioedema be managed?
What are the causes of unilateral (one-sided) tongue swelling or tongue allergy?
Is oral hydroxyzine 25 mg twice daily as needed appropriate for a 16‑year‑old adolescent with anxiety while awaiting a psychiatrist appointment?
Is azithromycin appropriate for treating a sore throat (pharyngitis) and purulent conjunctivitis?
Can you provide a SOAP note for a patient presenting with acute swelling of the anterior two‑thirds of the tongue (angioedema), with sudden onset, mild dysphonia and throat tightness, no drooling, vomiting, or urticaria, recent initiation of an ACE inhibitor, no prior episodes of angioedema, no asthma or atopic disease, vital signs showing normotension, mild tachycardia, normal respiratory rate, normal oxygen saturation, and afebrile?
What is the standard nebulized albuterol (salbutamol) dose for adults and pediatric patients?
What is the recommended first-line antibiotic therapy for human bite wounds, including tetanus prophylaxis and alternatives for penicillin-allergic patients?
In a patient with confirmed phantom human chorionic gonadotropin (hCG) and normal tumor marker hCG, what is the recommended ongoing surveillance schedule?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.